ERC banner
ETF Spotlight Newsletter
A sampling of research & data on ETFs from AltaVista Research
In This Issue
In This Issue
Chart of the week
Fund focus
New coverage
Special Offer
One month
Free Trial

Sign up here
Quick Links
Coverage at a glance
No. of ETFs
538

Total Mkt Cap ($bns)

$546.0

Avg. daily value traded ($bns)

$47.7
Join Our List
Join Our Mailing List
July 19, 2010
Greetings!

Below please find the ETF Spotlight newsletter for the week of July 19, containing highlights of the research and data on www.etfresearchcenter.com as well as a recap of the past week's action in the ETF market. 

With the year now more than half over we are looking ahead to where earnings estimates stand for 2011. Feel free to share it with others who may be interested. 
 
In this week's issue

technicianEstimate revisions
  • Chart of the week: Fastest growth in 2011 EPS
  • Fund Focus: Health Care Select Sector SPDR (XLV)
  • Revisions, asset flows & short interest
  • EPS estimates, growth rates and P/E multiples for major ETFs
  • Market monitor - movers & categories
To download the full newsletter click here.
 
Chart of the week
Fastest EPS growth in 2011
2011E EPS growth
ChartOfWeek

With the year more than half over many investors are beginning to look ahead to next year. For the major benchmark ETFs such as the S&P500 (SPY) and iShares MSCI EAFE (EFA) and Emerging Markets (EEM) funds, earnings growth is expected to slow dramatically next year.

So we scanned our database for ETFs holding stocks with the fastest overall EPS growth based on estimates for 2011. However, to help eliminate funds where earnings growth is mostly the result of easy comparisons against depressed earnings this year, we set an additional criteria that the current P/E ratio had to be less than 15x. A higher figure would be a good sign that current earnings were cyclically depressed.

The resulting list contains several Financial-related funds (where earnings are far below what they were a few years ago, but where low P/E multiples also imply the market does not expect them to attain previous levels of profitability anytime soon) as well as a number of commodity-related ETFs.

But this chart is only the starting point for ideas: we can't even rate the first fund on the list, the Claymore NYSE/Arca Airlines fund (FAA) because--though profits look decent this year and next--over the course of the business cycle airlines operate at a net loss. 

To download the full newsletter, click here.
 
Fund Focus
Health Care Select Sector SPDR (XLV)pharma_pills

Consensus estimates suggest sales growth in 2010 could rebound by double-digits but a dip in margins will limit EPS growth. Further, the apparent trend towards lower profitability (ROE) bears watching because it implies slower earnings growth going forward longer-term. Nonetheless, XLV trades at historically cheap P/E multiples (not to mention at a discount to the S&P500) and enjoys an ALTAR Score well above average.

To download the full newsletter, click here.
 
New Coverage
We have initiated coverage on the following ETFs...
As always your questions & feedback are most welcome.
 
Sincerely,
 
Michael Krause
AltaVista Research